Factors associated with rapid neurological improvement 24 h following intra-arterial thrombolytic treatment for acute ischemic stroke

Journal of NeuroInterventional Surgery

Volumn 5, Issue 1, 2013, Pages 35-39

  Christoforidis, Gregorgy ^a   Mohammad, Yousef M ^b   Khadir, Mohammed ^a   Yang, Ming ^c   Slivka, Andrew P ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b RUSH UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PROUROKINASE; UROKINASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NERVOUS SYSTEM PARAMETERS; PIA ARTERY; PRIORITY JOURNAL; RANKIN SCALE; RAPID NEUROLOGICAL IMPROVEMENT; REPERFUSION; RETROSPECTIVE STUDY; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84871438610     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010109     Document Type: Article

References (25)

1. Broderick JP, Lu M, Kothari R, et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS t-PA stroke trial. Stroke 2000;31:2335-41.
2. Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study. JAMA 1999;282:2003-11.
3. Del Zoppo G, Higashida R, Furlan A, et al. PROACT: a phase ii randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11. (Pubitemid 28046933)
4. Christoforidis GA, Mohammad Y, Kehagias D, et al. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789-97. (Pubitemid 43853681)
5. Theron J, Coskun O, Huet H, et al. Local intraarterial thrombolysis in the carotid territory. Interv Neuroradiol 1996; 2:111-26. (Pubitemid 126495284)
6. Liebeskind DS. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am 2005; 15:553-73. (Pubitemid 41796939)
7. Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:1923-4.
8. Khatri P, Neff J, Broderick JP, et al; for the IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;35:2400-3. (Pubitemid 41566966)
9. Arnold M, Nedeltchev K, Remonda L, et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373-6. (Pubitemid 41360974)
10. Anon. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
11. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;353:1245-51. (Pubitemid 28470336)
12. Weir C, Murray G, Dyker A, et al. Is hyperglycemia an independent predictor of poor outcome after acute stroke: results of a long term follow up study. BMJ 1997;314:1303-6. (Pubitemid 27183316)
13. Christoforidis GA, Karakasis C, Mohammad YM, et al. Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol 2009;30 :165-70.
14. Christoforidis GA, Slivka A, Mohammad Y, et al . Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 2007;38:1799-804. (Pubitemid 46847250)
15. Bozzao L, Fantozzi L, Bastianello S, et al. Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke 1989;20:735-40. (Pubitemid 19168116)
16. Kucinski T, Koch C, Eckert B, et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 2003; 45:11-18. (Pubitemid 36700809)
17. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke 2009; 40(3 Suppl):S24-7.
18. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848-54.
19. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome a metaanalysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
20. Hacke W, Kaste M, Bluhmki E, et al; for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
21. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
22. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-100. (Pubitemid 29473254)
23. Sarikaya H, Arnold M, Engelter ST, et al . Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke 2011;42:2498-502.
24. Christoforidis GA, Rink C, Abduljalil A, et al . An endovascular canine middle cerebral artery occlusion model for the study of leptomeningeal collateral recruitment. Invest Radiol 2011;46:34-40.
25. Zhang H, Prabhakar P, Sealock R, et al. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab 2010; 30:923.